Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease

Nature Communications

Volumn 7, Issue , 2016, Pages

  Mottawea, Walid ^a,b,c   Chiang, Cheng Kang ^a,b   Mühlbauer, Marcus ^d   Starr, Amanda E ^a,b   Butcher, James ^a,b   Abujamel, Turki ^a,b   Deeke, Shelley A ^a,b   Brandel, Annette ^a,b   Zhou, Hu ^b,e   Shokralla, Shadi ^f   Hajibabaei, Mehrdad ^f   Singleton, Ruth ^g   Benchimol, Eric I ^a,g   Jobin, Christian ^d   Mack, David R ^a,g   Figeys, Daniel ^a,b   Stintzi, Alain ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MANSOURA UNIVERSITY   (Egypt)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^f UNIVERSITY OF GUELPH   (Canada)

^g CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH SALICYLATE; HYDROGEN SULFIDE; MITOCHONDRIAL PROTEIN; PROTEOME; INTERLEUKIN 10;

DETOXIFICATION; DISEASE INCIDENCE; DISEASE TREATMENT; IMMUNE RESPONSE; MICROBIAL COMMUNITY; MITOCHONDRION; RELATIVE ABUNDANCE; SCAVENGING (CHEMISTRY); STOMACH CONTENT;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; ATOPOBIUM; ATOPOBIUM PARVULUM; CHILD; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DETOXIFICATION; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; FEMALE; HOST PARASITE INTERACTION; HUMAN; IN VIVO STUDY; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PANCOLITIS; PATHOGENESIS; ANIMAL; BACTERIUM; CLASSIFICATION; GENETICS; GERMFREE ANIMAL; ISOLATION AND PURIFICATION; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PHYLOGENY; PRESCHOOL CHILD;

ATOPOBIUM PARVULUM; MUS;

ADOLESCENT; ANIMALS; BACTERIA; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; GASTROINTESTINAL MICROBIOME; GERM-FREE LIFE; HUMANS; INTERLEUKIN-10; MALE; MICE; MICE, KNOCKOUT; PHYLOGENY;

EID: 84996569936     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms13419     Document Type: Article

References (68)

1. Rigoli, L. & Caruso, R. A. Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review. World J. Gastroenterol. 20, 10262-10278 (2014).
2. Li, J., Butcher, J., Mack, D. & Stintzi, A. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm. Bowel Dis. 21, 139-153 (2015).
3. Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392 (2014).
4. Hansen, R. et al. Microbiota of de novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am. J. Gastroenterol. 107, 1913-1922 (2012).
5. Kolho, K. L. et al. Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation. Am. J. Gastroenterol. 110, 921-930 (2015).
6. Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).
7. Papa, E. et al. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS ONE 7, e39242 (2012).
8. Presley, L. L. et al. Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface. Inflamm. Bowel Dis. 18, 409-417 (2012).
9. McHardy, I. H. et al. Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome 1, 17 (2013).
10. Walters, W. A., Xu, Z. & Knight, R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 588, 4223-4233 (2014).
11. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
12. Paulson, J. N., Stine, O. C., Bravo, H. C. & Pop, M. Differential abundance analysis for microbial marker-gene surveys. Nat. Methods 10, 1200-1202 (2013).
13. Salter, S. J. et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12, 87 (2014).
14. Schloss, P. D., Gevers, D. & Westcott, S. L. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE 6, e27310 (2011).
15. Carbonero, F., Benefiel, A. C., Alizadeh-Ghamsari, A. H. & Gaskins, H. R. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front. Physiol. 3, 448 (2012).
16. Tyanova, S. et al. Proteomic maps of breast cancer subtypes. Nat. Commun. 7, 10259 (2016).
17. Blachier, F. et al. Luminal sulfide and large intestine mucosa: friend or foe? Amino Acids 39, 335-347 (2010).
18. -/- ;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J. Immunol. 178, 6522-6532 (2007).
19. -/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm. Bowel Dis. 13, 1457-1466 (2007).
20. Suarez, F. L., Furne, J. K., Springfield, J. & Levitt, M. D. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology 114, 923-929 (1998).
21. Sifroni, K. G. et al. Mitochondrial respiratory chain in the colonic mucosal of patients with ulcerative colitis. Mol. Cell. Biochem. 342, 111-115 (2010).
22. O'Morain, C., Smethurst, P., Levi, J. & Peters, T. J. Subcellular fractionation of rectal biopsy homogenates from patients with inflammatory bowel disease. Scand. J. Gastroenterol. 20, 209-214 (1985).
23. Soderholm, J. D. et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut 50, 307-313 (2002).
24. Beltran, B. et al. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naive and treated Crohn's disease. Inflamm. Bowel Dis. 16, 76-86 (2010).
25. Restivo, N. L., Srivastava, M. D., Schafer, I. A. & Hoppel, C. L. Mitochondrial dysfunction in a patient with crohn disease: possible role in pathogenesis. J. Pediatr. Gastroenterol. Nutr. 38, 534-538 (2004).
26. Bar, F. et al. Mitochondrial gene polymorphisms that protect mice from colitis. Gastroenterology 145, 1055-1063 (2013).
27. Wang, A. et al. Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis. Am. J. Pathol. 184, 2516-2527 (2014).
28. Soderholm, J. D. et al. Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? Gastroenterology 117, 65-72 (1999).
29. Zeissig, S. et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56, 61-72 (2007).
30. Ramasamy, S., Singh, S., Taniere, P., Langman, M. J. & Eggo, M. C. Sulfidedetoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G288-G296 (2006).
31. Linden, D. R. Hydrogen sulfide signaling in the gastrointestinal tract. Antioxid. Redox Signal. 20, 818-830 (2014).
32. Quince, C. et al. Extensive modulation of the fecal metagenome in children with Crohn's disease during exclusive enteral nutrition. Am. J. Gastroenterol. 110, 1718-1729 (2015).
33. Miller, T. W. et al. Hydrogen sulfide is an endogenous potentiator of T cell activation. J. Biol. Chem. 287, 4211-4221 (2012).
34. Ijssennagger, N. et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc. Natl Acad. Sci. USA 112, 10038-10043 (2015).
35. Guo, F. F., Yu, T. C., Hong, J. & Fang, J. Y. Emerging roles of hydrogen sulfide in inflammatory and neoplastic colonic diseases. Front. Physiol. 7, 156 (2016).
36. Wang, R. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol. Rev. 92, 791-896 (2012).
37. Gerasimidis, K. et al. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm. Bowel Dis. 20, 861-871 (2014).
38. Ungaro, R. et al. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis. Am. J. Gastroenterol. 109, 1728-1738 (2014).
39. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J. Pediatr. Gastroenterol. Nutr. 44, 653-674 (2007).
40. Levine, A. et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm. Bowel Dis. 17, 1314-1321 (2011).
41. Hyams, J. et al. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J. Pediatr. Gastroenterol. Nutr. 41, 416-421 (2005).
42. Turner, D. et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 133, 423-432 (2007).
43. Harris, P. A. et al. Research electronic data capture (REDCap)-a metadatadriven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42, 377-381 (2009).
44. Jimenez-Rivera, C., Haas, D., Boland, M., Barkey, J. L. & Mack, D. R. Comparison of two common outpatient preparations for colonoscopy in children and youth. Gastroenterol. Res. Pract. 2009, 518932 (2009).
45. Sundquist, A. et al. Bacterial flora-typing with targeted, chip-based Pyrosequencing. BMC Microbiol. 7, 108 (2007).
46. Magoc, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963 (2011).
47. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
48. Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics 23, 127-128 (2007).
49. Letunic, I. & Bork, P. Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res. 39, W475-W478 (2011).
50. McMurdie, P. J. & Holmes, S. Phyloseq: a bioconductor package for handling and analysis of high-throughput phylogenetic sequence data. Pac. Symp. Biocomput. 235-246 (2012).
51. Milani, C. et al. Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. PLoS ONE 8, e68739 (2013).
52. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
53. Aronesty, E. ea-utils: 'Command-line tools for processing biological sequencing data'. https://github.com/ExpressionAnalysis/ea-utils (2011).
54. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
55. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
56. Cole, J. R. et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37, D141-D145 (2009).
57. Hippe, B. et al. Quantification of butyryl CoA:acetate CoA-transferase genes reveals different butyrate production capacity in individuals according to diet and age. FEMS Microbiol. Lett. 316, 130-135 (2011).
58. Louis, P. & Flint, H. J. Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl. Environ. Microbiol. 73, 2009-2012 (2007).
59. Walker, A. W. et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5, 220-230 (2011).
60. Faust, K. et al. Microbial co-occurrence relationships in the human microbiome. PLoS Comput. Biol. 8, e1002606 (2012).
61. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003).
62. Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362 (2009).
63. Stahl, M. et al. L-fucose utilization provides Campylobacter jejuni with a competitive advantage. Proc. Natl Acad. Sci. USA 108, 7194-7199 (2011).
64. Palmer, C., Bik, E. M., Di Giulio, D. B., Relman, D. A. & Brown, P. O. Development of the human infant intestinal microbiota. PLoS Biol. 5, e177 (2007).
65. Ye, J. et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13, 134 (2012).
66. Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123 (2012).
67. Sun, X., Threadgill, D. & Jobin, C. Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling. Gastroenterology 142, 86-95 (2012).
68. Lippert, E. et al. Gnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylobacter jejuni infection. PLoS ONE 4, e7413 (2009).